Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

United Therapeutics

Clinical trials sponsored by United Therapeutics, explained in plain language.

Trials to join now! 5 Not yet finished but already full! 3 Completed 2 Terminated 1
Sort by
  • New hope to slow deadly lung disease progression

    Disease control Completed

    This study tested whether adding a new drug called ralinepag to standard treatments could help people with pulmonary arterial hypertension (PAH), a serious lung and heart condition. It involved 687 adults with PAH who were already on stable medication. The main goal was to see if…

    Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control

    Last updated Mar 30, 2026 14:28 UTC

  • New inhaled therapy tested to slow scarring lung disease

    Disease control Completed

    This study tested whether an inhaled medication called treprostinil could help slow the decline of lung function in people with idiopathic pulmonary fibrosis (IPF), a serious scarring lung disease. About 600 participants were randomly assigned to receive either the active drug or…

    Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control

    Last updated Mar 23, 2026 15:17 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space